![James Panek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Panek
Directeur/Bestuurslid bij
SUTRO BIOPHARMA, INC.
Vermogen: - $ op 31-05-2026
Profiel
James P.
Panek is currently an Independent Director at Sutro Biopharma, Inc. since 2020 and Chief Operating Officer at CHO Plus, Inc. Formerly, Dr. Panek was Chairman & Co-Chief Executive Officer at Celltrion, Inc. from 2002 to 2006, President, Chief Executive Officer, CFO & Director at Diadexus, Inc. from 2010 to 2011, President, Chief Financial Officer, CAO & Director at VaxGen, Inc. from 2007 to 2010, Director at diaDexus, Inc., and Senior Vice President-Product Operations at Genentech, Inc. from 1982 to 2001.
Education includes undergraduate and graduate degrees from the University of Michigan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van James Panek
| Bedrijven | Functie | Begin |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur/Bestuurslid | 07-01-2020 |
Cho Plus, Inc.
 Cho Plus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops patented cell-engineering technologies for mammalian cells | Operationeel Directeur | - |
Eerdere bekende functies van James Panek
| Bedrijven | Functie | Einde |
|---|---|---|
| DIADEXUS, INC. | Algemeen Directeur | 01-01-2011 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Directeur/Bestuurslid | 01-11-2010 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Financieel Directeur/CFO | 01-01-2010 |
| CELLTRION, INC. | Algemeen Directeur | 01-01-2006 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2001 |
Opleiding van James Panek
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
 Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Cho Plus, Inc.
Cho Plus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops patented cell-engineering technologies for mammalian cells | Health Technology |
